Autoimmunity	NN	autoimmunity NN PennPOS
to	TO	to p-acp NUPOS
Vimentin	NNP	vimentin NN PennPOS
Is	VBZ	be vbz NUPOS
Associated	VBN	associate VBN PennPOS
with	IN	with pp NUPOS
Outcomes	NNS	outcome NNS PennPOS
of	IN	of pp-f NUPOS
Patients	NNS	patient NNS PennPOS
with	IN	with pp NUPOS
Idiopathic	JJ	idiopathic JJ PennPOS
Pulmonary	JJ	pulmonary JJ PennPOS
Fibrosis	NN	fibrosis NN PennPOS
.	.	. . NUPOS

Autoimmunity	NN	autoimmunity NN PennPOS
has	VBZ	have vdz NUPOS
been	VBN	be vbn NUPOS
implicated	VBN	implicate VBN PennPOS
in	IN	in IN PennPOS
the	DT	the dt NUPOS
pathogenesis	NN	pathogenesis NN PennPOS
of	IN	of pp-f NUPOS
idiopathic	JJ	idiopathic JJ PennPOS
pulmonary	JJ	pulmonary JJ PennPOS
fibrosis	NN	fibrosis NN PennPOS
(	(	( ( NUPOS
IPF	NN	IPF NN PennPOS
)	)	) ) NUPOS
;	:	; : NUPOS
however	RB	however a-acp NUPOS
,	,	, , NUPOS
the	DT	the dt NUPOS
repertoire	NN	repertoire NN PennPOS
of	IN	of pp-f NUPOS
autoantigens	NNS	autoantigen NNS PennPOS
involved	VBN	involve VBN PennPOS
in	IN	in IN PennPOS
this	DT	this d NUPOS
disease	NN	disease NN PennPOS
and	CC	and cc NUPOS
the	DT	the dt NUPOS
clinical	JJ	clinical JJ PennPOS
relevance	NN	relevance NN PennPOS
of	IN	of pp-f NUPOS
these	DT	these d NUPOS
autoimmune	JJ	autoimmune JJ PennPOS
responses	NNS	response NNS PennPOS
are	VBP	be vbb NUPOS
still	RB	still av NUPOS
being	VBG	be vbg NUPOS
explored	VBN	explore VBN PennPOS
.	.	. . NUPOS

Our	PRP$	our po12 NUPOS
initial	JJ	initial JJ PennPOS
discovery	NN	discovery NN PennPOS
assays	NNS	assay n2 NUPOS
demonstrated	VBD	demonstrate VBD PennPOS
that	IN	that cst NUPOS
circulating	VBG	circulate VBG PennPOS
and	CC	and cc NUPOS
intrapulmonary	JJ	intrapulmonary JJ PennPOS
vimentin	NN	vimentin NN PennPOS
levels	NNS	level NNS PennPOS
are	VBP	be vbb NUPOS
increased	VBN	increase VBN PennPOS
in	IN	in IN PennPOS
IPF	NN	IPF NN PennPOS
patients	NNS	patient NNS PennPOS
.	.	. . NUPOS

Subsequent	JJ	subsequent JJ PennPOS
studies	NNS	study NNS PennPOS
showed	VBD	show VBN PennPOS
native	JJ	native JJ PennPOS
vimentin	NN	vimentin NN PennPOS
induced	VBD	induce VBD PennPOS
HLA-DR-dependent	JJ	hla-dr-dependent JJ PennPOS
in	FW	in fw-la NUPOS
vitro	FW	vitro FW PennPOS
proliferation	NN	proliferation NN PennPOS
of	IN	of pp-f NUPOS
CD4	NN	CD4 NN PennPOS
T	NN	T NN PennPOS
cells	NNS	cell NNS PennPOS
from	IN	from pp NUPOS
IPF	NN	IPF NN PennPOS
patients	NNS	patient NNS PennPOS
and	CC	and cc NUPOS
enhanced	VBD	enhance VBD PennPOS
the	DT	the dt NUPOS
production	NN	production NN PennPOS
of	IN	of pp-f NUPOS
IL-4	NN	IL-4 NN PennPOS
,	,	, , NUPOS
IL-17	NN	IL-17 NN PennPOS
,	,	, , NUPOS
and	CC	and cc NUPOS
TGF-b1	NN	TGF-b1 NN PennPOS
by	IN	by IN PennPOS
these	DT	these d NUPOS
lymphocytes	NNS	lymphocyte NNS PennPOS
in	IN	in IN PennPOS
contrast	NN	contrast NN PennPOS
to	TO	to p-acp NUPOS
normal	JJ	normal JJ PennPOS
control	NN	control NN PennPOS
specimens	NNS	specimen NNS PennPOS
.	.	. . NUPOS

Vimentin	NN	vimentin NN PennPOS
supplementation	NN	supplementation NN PennPOS
of	IN	of pp-f NUPOS
IPF	NN	IPF NN PennPOS
PBMC	NN	pbmc NN PennPOS
cultures	NNS	culture NNS PennPOS
also	RB	also av NUPOS
resulted	VBD	result VBD PennPOS
in	IN	in IN PennPOS
HLA-DR-dependent	JJ	hla-dr-dependent JJ PennPOS
production	NN	production NN PennPOS
of	IN	of pp-f NUPOS
IgG	NN	IgG NN PennPOS
with	IN	with pp NUPOS
anti-vimentin	JJ	anti-vimentin JJ PennPOS
specificities	NNS	specificity NNS PennPOS
.	.	. . NUPOS

Circulating	VBG	circulate VBG PennPOS
anti-vimentin	JJ	anti-vimentin JJ PennPOS
IgG	NN	IgG NN PennPOS
autoantibody	NN	autoantibody NN PennPOS
levels	NNS	level NNS PennPOS
were	VBD	be vbd NUPOS
much	RB	much RB PennPOS
greater	JJR	great JJR PennPOS
in	IN	in IN PennPOS
IPF	NN	IPF NN PennPOS
subjects	NNS	subject NNS PennPOS
from	IN	from pp NUPOS
the	DT	the dt NUPOS
University	NNP	university NN PennPOS
of	IN	of pp-f NUPOS
Alabama	NNP	alabama NN PennPOS
at	IN	at pp NUPOS
Birmingham	NNP	birmingham NN PennPOS
(	(	( ( NUPOS
n	NN	n NN PennPOS
=	JJ	= JJ PennPOS
102	CD	102 crd NUPOS
)	)	) ) NUPOS
and	CC	and cc NUPOS
the	DT	the dt NUPOS
University	NNP	university NN PennPOS
of	IN	of pp-f NUPOS
Pittsburgh	NNP	pittsburgh NN PennPOS
(	(	( ( NUPOS
U.	NNP	U. np1 NUPOS
Pitt.	NNP	Pitt. NNP PennPOS
,	,	, , NUPOS
n	NN	n NN PennPOS
=	JJ	= JJ PennPOS
70	CD	70 crd NUPOS
)	)	) ) NUPOS
than	IN	than cs NUPOS
in	IN	in IN PennPOS
normal	JJ	normal JJ PennPOS
controls	NNS	control NNS PennPOS
.	.	. . NUPOS

Anti-vimentin	JJ	anti-vimentin JJ PennPOS
autoantibody	NN	autoantibody NN PennPOS
levels	NNS	level NNS PennPOS
in	IN	in IN PennPOS
IPF	NN	IPF NN PennPOS
patients	NNS	patient NNS PennPOS
were	VBD	be vbd NUPOS
HLA	NN	hla NN PennPOS
biased	VBN	bias VBN PennPOS
and	CC	and cc NUPOS
inversely	RB	inverse av-j NUPOS
correlated	VBD	correlate VBD PennPOS
with	IN	with pp NUPOS
physiological	JJ	physiological JJ PennPOS
measurements	NNS	measurement NNS PennPOS
of	IN	of pp-f NUPOS
lung	NN	lung NN PennPOS
function	NN	function NN PennPOS
(	(	( ( NUPOS
i.e.	FW	i.e. FW PennPOS
,	,	, , NUPOS
forced	VBD	force VBD PennPOS
expiratory	JJ	expiratory JJ PennPOS
volumes	NNS	volume NNS PennPOS
and	CC	and cc NUPOS
diffusing	VBG	diffuse VBG PennPOS
capacities	NNS	capacity NNS PennPOS
)	)	) ) NUPOS
.	.	. . NUPOS

Despite	IN	despite pp NUPOS
considerable	JJ	considerable JJ PennPOS
intergroup	NN	intergroup NN PennPOS
differences	NNS	difference NNS PennPOS
in	IN	in IN PennPOS
transplant-free	JJ	transplant-free JJ PennPOS
survival	NN	survival NN PennPOS
between	IN	between IN PennPOS
these	DT	these d NUPOS
two	CD	two crd NUPOS
independent	JJ	independent JJ PennPOS
IPF	NN	IPF NN PennPOS
cohorts	NNS	cohort NNS PennPOS
,	,	, , NUPOS
serious	JJ	serious JJ PennPOS
adverse	JJ	adverse JJ PennPOS
outcomes	NNS	outcome NNS PennPOS
were	VBD	be vbd NUPOS
most	RBS	much RBS PennPOS
frequent	JJ	frequent JJ PennPOS
among	IN	among IN PennPOS
the	DT	the dt NUPOS
patients	NNS	patient NNS PennPOS
within	IN	within pp NUPOS
each	DT	each d NUPOS
population	NN	population NN PennPOS
that	WDT	that WDT PennPOS
had	VBD	have vhd NUPOS
the	DT	the dt NUPOS
highest	JJS	high JJS PennPOS
anti-vimentin	JJ	anti-vimentin JJ PennPOS
autoantibody	NN	autoantibody NN PennPOS
levels	NNS	level NNS PennPOS
(	(	( ( NUPOS
University	NNP	university NN PennPOS
of	IN	of pp-f NUPOS
Alabama	NNP	alabama NN PennPOS
at	IN	at pp NUPOS
Birmingham	NNP	birmingham NN PennPOS
:	:	: : NUPOS
hazard	NN	hazard NN PennPOS
ratio	NN	ratio NN PennPOS
2.5	CD	2.5 CD PennPOS
,	,	, , NUPOS
95	CD	95 CD PennPOS
%	NN	% NN PennPOS
confidence	NN	confidence NN PennPOS
interval	NN	interval NN PennPOS
1.2-5.3	CD	1.2-5.3 CD PennPOS
,	,	, , NUPOS
p	NN	p NN PennPOS
=	JJ	= JJ PennPOS
0.012	CD	0.012 CD PennPOS
;	:	; : NUPOS
University	NNP	university NN PennPOS
of	IN	of pp-f NUPOS
Pittsburgh	NNP	pittsburgh NN PennPOS
:	:	: : NUPOS
hazard	NN	hazard NN PennPOS
ratio	NN	ratio NN PennPOS
2.7	CD	2.7 CD PennPOS
,	,	, , NUPOS
95	CD	95 CD PennPOS
%	NN	% NN PennPOS
confidence	NN	confidence NN PennPOS
interval	NN	interval NN PennPOS
1.3-5.5	CD	1.3-5.5 CD PennPOS
,	,	, , NUPOS
p	NN	p NN PennPOS
=	JJ	= JJ PennPOS
0.006	CD	0.006 CD PennPOS
)	)	) ) NUPOS
.	.	. . NUPOS

These	DT	these d NUPOS
data	NNS	datum NNS PennPOS
show	VBP	show VBP PennPOS
that	IN	that cst NUPOS
anti-vimentin	JJ	anti-vimentin JJ PennPOS
autoreactivity	NN	autoreactivity NN PennPOS
is	VBZ	be vbz NUPOS
prevalent	JJ	prevalent JJ PennPOS
in	IN	in IN PennPOS
IPF	NN	IPF NN PennPOS
patients	NNS	patient NNS PennPOS
and	CC	and cc NUPOS
is	VBZ	be vbz NUPOS
strongly	RB	strong av-j NUPOS
associated	VBN	associate VBN PennPOS
with	IN	with pp NUPOS
disease	NN	disease NN PennPOS
manifestations	NNS	manifestation NNS PennPOS
.	.	. . NUPOS

These	DT	these d NUPOS
findings	NNS	finding n2 NUPOS
have	VBP	have vhb NUPOS
implications	NNS	implication NNS PennPOS
with	IN	with pp NUPOS
regard	NN	regard NN PennPOS
to	TO	to p-acp NUPOS
the	DT	the dt NUPOS
pathogenesis	NN	pathogenesis NN PennPOS
of	IN	of pp-f NUPOS
this	DT	this d NUPOS
enigmatic	JJ	enigmatic JJ PennPOS
disease	NN	disease NN PennPOS
and	CC	and cc NUPOS
raise	VB	raise VBP PennPOS
the	DT	the dt NUPOS
possibility	NN	possibility NN PennPOS
that	IN	that cst NUPOS
therapies	NNS	therapy NNS PennPOS
specifically	RB	specific av-j NUPOS
directed	VBN	direct VBN PennPOS
at	IN	at pp NUPOS
these	DT	these d NUPOS
autoimmune	JJ	autoimmune JJ PennPOS
processes	NNS	process n2 NUPOS
could	MD	can vmd NUPOS
have	VB	have vhi NUPOS
therapeutic	JJ	therapeutic JJ PennPOS
efficacy	NN	efficacy NN PennPOS
.	.	. . NUPOS

